Territorial heterogeneity in healthcare accessibility: going beyond the APL indicator
Arnaud Chéron, Franck Maunoury and Anthony Terriau — TEPP Research Report 2025-06.
View researchScientific expertise for better health decisions
Statésia supports healthcare stakeholders in evaluating innovative products, technologies and strategies, from evidence to decision.
Our areas of expertise
This decision analysis is based on:
1- Comparative Effectiveness Research, Indirect and Mixed Treatment Comparisons (MTC, NMA) : Positioning your innovative technology in the studied therapeutic area;
2- Interactive Health Economics Modeling: Assessing the cost-effectiveness, the cost-utility or the cost-benefit of your innovative health product or technology;
3- Interactive Budget Impact Analysis (IBIA) : Assessing the affordability of your innovative product;
4- Medico-economic real life studies.
News
Arnaud Chéron, Franck Maunoury and Anthony Terriau — TEPP Research Report 2025-06.
View researchRobert Launois, Elise Meto, Elise Cabout and Franck Maunoury — ESKA, Paris.
View publicationMaunoury F. et al. — PLoS ONE, CLEAN-3 study.
View publicationReferences and publications
Study reports, publications, conferences and posters: explore Statésia’s work.
A project?
Let’s discuss your objectives, data and the most appropriate methodological framework.